MARK CHEN

LAS VEGAS, NV

This page merges CMS profile IDs: 11388684, 8806952 (associated profiles published by CMS for the same provider; see the provenance section below).

General Payments — all program years on this page

$1,139.71

  • Category: General Payments
  • Program years: PY2020–2024
  • Record count: 37
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $734.09 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $734.0922

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2020 $15.771
2022 $111.936
2023 $277.928
2024 $734.0922

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078099838 Janssen Pharmaceuticals, Inc $17.20 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086201548 Bayer Healthcare Pharmaceuticals Inc. $53.92 09/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086661769 Novartis Pharmaceuticals Corporation $19.92 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103452952 ABBVIE INC. $23.58 08/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103452954 ABBVIE INC. $15.64 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104272807 AstraZeneca Pharmaceuticals LP $14.86 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113464955 Kowa Pharmaceuticals America, Inc. $13.50 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117769300 Corcept Therapeutics $7.51 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117769306 Corcept Therapeutics $19.25 09/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117769372 Corcept Therapeutics $129.43 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131463588 PFIZER INC. $18.79 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131506296 PFIZER INC. $25.72 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131525721 PFIZER INC. $19.11 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131571922 PFIZER INC. $23.94 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131572006 PFIZER INC. $14.15 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133635993 Gilead Sciences, Inc. $118.74 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143205989 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.92 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144087735 Solventum Corporation $28.13 08/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149612090 Smith+Nephew, Inc. $15.22 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149612092 Smith+Nephew, Inc. $16.65 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153319758 Dexcom, Inc. $22.10 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153319760 Dexcom, Inc. $91.81 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
  • Merged CMS profile IDs: 11388684, 8806952

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.